SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-20-012393
Filing Date
2020-11-27
Accepted
2020-11-25 17:56:49
Documents
16

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 2629616
2 GRAPHIC g19910g04d64.jpg GRAPHIC 38009
3 GRAPHIC g19910g11m86.jpg GRAPHIC 56468
4 GRAPHIC g19910g17t35.jpg GRAPHIC 88530
5 GRAPHIC g19910g18q03.jpg GRAPHIC 69198
6 GRAPHIC g19910g23x77.jpg GRAPHIC 84955
7 GRAPHIC g19910g26q63.jpg GRAPHIC 102830
8 GRAPHIC g19910g32s63.jpg GRAPHIC 631373
9 GRAPHIC g19910g32w78.jpg GRAPHIC 131527
10 GRAPHIC g19910g39u54.jpg GRAPHIC 620416
11 GRAPHIC g19910g44w12.jpg GRAPHIC 79629
12 GRAPHIC g19910g50k03.jpg GRAPHIC 37351
13 GRAPHIC g19910g61e40.jpg GRAPHIC 46663
14 GRAPHIC g19910g96w28.jpg GRAPHIC 605101
15 GRAPHIC g19910g98e91.jpg GRAPHIC 39422
16 GRAPHIC g19910g99t25.jpg GRAPHIC 72972
  Complete submission text file 0000950123-20-012393.txt   6270226
Mailing Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD STEVENAGE X0 SG1 2FX
Business Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD STEVENAGE X0 SG1 2FX 44 (0) 1438 906855
Achilles Therapeutics Ltd (Filer) CIK: 0001830749 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-03834 | Film No.: 201352251
SIC: 2836 Biological Products, (No Diagnostic Substances)